GNC Targets ‘Consumer Trust’ In N.Y. Agreement, But Industry Wary Of Impact
This article was originally published in The Pink Sheet Daily
Executive Summary
As GNC explains why it accepted an agreement with N.Y. to resolve accusations about adulterated herbal supplements, industry stakeholders at Ingredient Marketplace discuss strategies on refuting those allegations and informing consumers about the quality control that is a hallmark for much of the industry.
You may also be interested in...
Making Nutritionals Eligible For Health Savings Accounts Whets Congress' Appetite
The supplement Industry and members of Congress open a line of communication on including dietary supplements into FSA/HSA spending programs, says CRN President Steve Mister.
J&J Settlement With States Not Likely To Be Precedent In OTC Space
J&J's agreement with 42 states and Washington, D.C. is its latest cost from widespread GMP problems that prompted recalls and led to a 2011 FDA consent decree. But the unusual combination of factors suggest more such state actions are unlikely to follow.
J&J Settlement With States Not Likely To Be Precedent In OTC Space
J&J's agreement with 42 states and Washington, D.C. is its latest cost from widespread GMP problems that prompted recalls and led to a 2011 FDA consent decree. But the unusual combination of factors suggest more such state actions are unlikely to follow.